Portfolio company
Immunet
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops cloud-based antivirus software for individual and commercial customers to protect computers against malware threats.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Immulus
The company develops manufacturing processes to selectively expand T-cells for drug development for pharmaceutical and biotechnology customers.
Immunai
Immunai develops an immune system mapping platform for biopharmaceutical companies to discover and optimise drug targets and clinical trials.
Immunara
This company develops biological foundation models and artificial intelligence to map immune system interactions for pharmaceutical and biotechnology researchers.
immunos
This biotechnology company develops immunomodulatory proteins and HLA-based biologic therapies for pharmaceutical companies and healthcare providers to treat cancer and autoimmune diseases.
Centivax
This company develops broad-spectrum vaccines and monoclonal antibodies using computational immune engineering to protect against infectious diseases and pathogens for global healthcare systems.
Inimmune
The company develops immunotherapies and vaccine components to treat patients with allergies, cancer, infectious diseases and autoimmune conditions.
Medicalcloudcompany
This company develops patient empowerment applications and clinical decision support systems for patients and healthcare providers, primarily within oncology and infectious disease sectors.
ImmuneSpec
This company provides immunopeptidomics analysis services to biotechnology and pharmaceutical firms to support vaccine development, immunotherapy research and biotherapeutic immunogenicity risk assessment.